3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase NA
2
Phase EARLY_PHASE1
1
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neoplasm Metastasis
33
Leukemia, Myeloid, Acute
24
Melanoma
14
Colorectal Neoplasms
14
Breast Neoplasms
14
Multiple Myeloma
13
Myelodysplastic Syndromes
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Pancreatic Neoplasms
10
Lymphoma, Follicular
10
Prostatic Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, Large B-Cell, Diffuse
8
Triple Negative Breast Neoplasms
7
Lymphoma, Non-Hodgkin
7
Lymphoma, Mantle-Cell
7
Lung Neoplasms
7
Burkitt Lymphoma
7
Ovarian Neoplasms
6
Lymphoma, B-Cell, Marginal Zone
6
Stomach Neoplasms
5
Sarcoma
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, T-Cell
5
Lymphoma, B-Cell
5
Lymphoma
5
Leukemia, Biphenotypic, Acute
5
Carcinoma, Renal Cell
5
Carcinoma, Non-Small-Cell Lung
5
Unspecified Adult Solid Tumor, Protocol Specific
4
Interventions
Temozolomide
11
Filgrastim
5
Magnetic Resonance Spectroscopy
4
Cyclophosphamide
4
Carmustine
4
Thiotepa
3
Radiation
3
Etoposide
3
Carboplatin
3
Azacitidine
3
Automobiles
3
sargramostim
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
ONC206
2
O(6)-benzylguanine
2
Nivolumab
2
Melphalan
2
Immunohistochemistry
2
Imiquimod
2
Imatinib Mesylate
2
Granulocyte Colony-Stimulating Factor
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
2
1-methyltryptophan
2
vitespin
1
veliparib
1
vatalanib
1
trametinib
1
thymoglobulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Ependymoma
×
Biopsy
×
Clear all
NCT07031765
2025-12-18
Peds CHAMP1ON
University of Florida
Phase 1
Active not recruiting
12 enrolled